ID   HNRPF_HUMAN             Reviewed;         415 AA.
AC   P52597; B3KM84; Q5T0N2; Q96AU2;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   28-JUN-2023, entry version 233.
DE   RecName: Full=Heterogeneous nuclear ribonucleoprotein F;
DE            Short=hnRNP F;
DE   AltName: Full=Nucleolin-like protein mcs94-1;
DE   Contains:
DE     RecName: Full=Heterogeneous nuclear ribonucleoprotein F, N-terminally processed;
GN   Name=HNRNPF; Synonyms=HNRPF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 52-61; 78-83 AND
RP   128-136.
RX   PubMed=7512260; DOI=10.1093/nar/22.6.1059;
RA   Matunis M.J., Xing J., Dreyfuss G.;
RT   "The hnRNP F protein: unique primary structure, nucleic acid-binding
RT   properties, and subcellular localization.";
RL   Nucleic Acids Res. 22:1059-1067(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=7499401; DOI=10.1074/jbc.270.48.28780;
RA   Honore B., Rasmussen H.H., Vorum H., Dejgaard K., Liu X., Gromov P.,
RA   Madsen P., Gesser B., Tommerup N., Celis J.E.;
RT   "Heterogeneous nuclear ribonucleoproteins H, H', and F are members of a
RT   ubiquitously expressed subfamily of related but distinct proteins encoded
RT   by genes mapping to different chromosomes.";
RL   J. Biol. Chem. 270:28780-28789(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1351868; DOI=10.1016/0888-7543(92)90251-m;
RA   McDonald H., Smailus D., Jenkins H., Adams K., Simpson N.E.,
RA   Goodfellow P.J.;
RT   "Identification and characterization of a gene at D10S94 in the MEN2A
RT   region.";
RL   Genomics 13:344-348(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-87.
RC   TISSUE=Bone marrow, Lung, Ovary, Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 1-14; 53-68; 82-87; 99-114; 151-167; 180-185 AND
RP   300-347, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT MET-1 AND MET-2,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma, and Colon carcinoma;
RA   Bienvenut W.V., Zebisch A., Kolch W.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [9]
RP   INTERACTION WITH TXNL4.
RX   PubMed=11054566; DOI=10.1016/s0378-1119(00)00372-3;
RA   Zhang Y.-Z., Lindblom T., Chang A., Sudol M., Sluder A.E., Golemis E.A.;
RT   "Evidence that Dim1 associates with proteins involved in pre-mRNA splicing,
RT   and delineation of residues essential for Dim1 interactions with hnRNP F
RT   and Npw38/PQBP-1.";
RL   Gene 257:33-43(2000).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE SPLICEOSOMAL
RP   C COMPLEX.
RX   PubMed=11991638; DOI=10.1017/s1355838202021088;
RA   Jurica M.S., Licklider L.J., Gygi S.P., Grigorieff N., Moore M.J.;
RT   "Purification and characterization of native spliceosomes suitable for
RT   three-dimensional structural analysis.";
RL   RNA 8:426-439(2002).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [12]
RP   SUMOYLATION AT LYS-72.
RX   PubMed=15161980; DOI=10.1073/pnas.0402889101;
RA   Li T., Evdokimov E., Shen R.F., Chao C.C., Tekle E., Wang T.,
RA   Stadtman E.R., Yang D.C., Chock P.B.;
RT   "Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger
RT   proteins, and nuclear pore complex proteins: a proteomic analysis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:8551-8556(2004).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [14]
RP   INTERACTION WITH AGO1 AND AGO2.
RX   PubMed=17932509; DOI=10.1038/sj.embor.7401088;
RA   Hoeck J., Weinmann L., Ender C., Ruedel S., Kremmer E., Raabe M.,
RA   Urlaub H., Meister G.;
RT   "Proteomic and functional analysis of Argonaute-containing mRNA-protein
RT   complexes in human cells.";
RL   EMBO Rep. 8:1052-1060(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND MET-2, CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-224, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104 AND SER-187, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND MET-2, CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104; SER-107; SER-193;
RP   THR-215 AND SER-265, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-200, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [29]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-87; LYS-167; LYS-185; LYS-200 AND
RP   LYS-224, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [30]
RP   STRUCTURE BY NMR OF 1-102; 103-194 AND 277-381 IN COMPLEX WITH BCL-X RNA,
RP   AND MUTAGENESIS OF PHE-120; PHE-156; HIS-178 AND TYR-180.
RX   PubMed=16885237; DOI=10.1093/nar/gkl488;
RA   Dominguez C., Allain F.H.;
RT   "NMR structure of the three quasi RNA recognition motifs (qRRMs) of human
RT   hnRNP F and interaction studies with Bcl-x G-tract RNA: a novel mode of RNA
RT   recognition.";
RL   Nucleic Acids Res. 34:3634-3645(2006).
RN   [31]
RP   STRUCTURE BY NMR OF 1-194 AND 277-381 IN COMPLEXES WITH AGGGAU RNA
RP   OLIGONUCLEOTIDE, FUNCTION, AND MUTAGENESIS OF TRP-20; GLU-84; ARG-116;
RP   PHE-120; LYS-150; LYS-173; ARG-179; TYR-180; GLU-182 AND PHE-184.
RX   PubMed=20526337; DOI=10.1038/nsmb.1814;
RA   Dominguez C., Fisette J.F., Chabot B., Allain F.H.;
RT   "Structural basis of G-tract recognition and encaging by hnRNP F quasi-
RT   RRMs.";
RL   Nat. Struct. Mol. Biol. 17:853-861(2010).
CC   -!- FUNCTION: Component of the heterogeneous nuclear ribonucleoprotein
CC       (hnRNP) complexes which provide the substrate for the processing events
CC       that pre-mRNAs undergo before becoming functional, translatable mRNAs
CC       in the cytoplasm. Plays a role in the regulation of alternative
CC       splicing events. Binds G-rich sequences in pre-mRNAs and keeps target
CC       RNA in an unfolded state. {ECO:0000269|PubMed:20526337}.
CC   -!- SUBUNIT: Identified in the spliceosome C complex. Interacts with AGO1,
CC       AGO2, TBP and TXNL4/DIM1. {ECO:0000269|PubMed:11054566,
CC       ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:16885237,
CC       ECO:0000269|PubMed:17932509}.
CC   -!- INTERACTION:
CC       P52597; Q53H80: AKIRIN2; NbExp=3; IntAct=EBI-352986, EBI-742928;
CC       P52597; P41238: APOBEC1; NbExp=3; IntAct=EBI-352986, EBI-12819523;
CC       P52597; Q86V38: ATN1; NbExp=3; IntAct=EBI-352986, EBI-11954292;
CC       P52597; Q9Y6H3: ATP23; NbExp=3; IntAct=EBI-352986, EBI-12811889;
CC       P52597; Q9BXC9: BBS2; NbExp=3; IntAct=EBI-352986, EBI-748297;
CC       P52597; Q5SWW7: C10orf55; NbExp=3; IntAct=EBI-352986, EBI-12809220;
CC       P52597; Q6P1W5: C1orf94; NbExp=6; IntAct=EBI-352986, EBI-946029;
CC       P52597; Q8N684-3: CPSF7; NbExp=3; IntAct=EBI-352986, EBI-11523759;
CC       P52597; Q86Y13: DZIP3; NbExp=6; IntAct=EBI-352986, EBI-948630;
CC       P52597; Q9NRA8: EIF4ENIF1; NbExp=3; IntAct=EBI-352986, EBI-301024;
CC       P52597; Q9NVL1-2: FAM86C1P; NbExp=3; IntAct=EBI-352986, EBI-12845222;
CC       P52597; A0A024R5S0: hCG_2003792; NbExp=3; IntAct=EBI-352986, EBI-10188461;
CC       P52597; P31943: HNRNPH1; NbExp=3; IntAct=EBI-352986, EBI-351590;
CC       P52597; P52272: HNRNPM; NbExp=6; IntAct=EBI-352986, EBI-486809;
CC       P52597; Q9BUJ2: HNRNPUL1; NbExp=5; IntAct=EBI-352986, EBI-1018153;
CC       P52597; Q96LI6: HSFY2; NbExp=3; IntAct=EBI-352986, EBI-3957665;
CC       P52597; Q9UKT9: IKZF3; NbExp=3; IntAct=EBI-352986, EBI-747204;
CC       P52597; Q0VD86: INCA1; NbExp=3; IntAct=EBI-352986, EBI-6509505;
CC       P52597; Q6IPM2: IQCE; NbExp=3; IntAct=EBI-352986, EBI-3893098;
CC       P52597; Q92993: KAT5; NbExp=3; IntAct=EBI-352986, EBI-399080;
CC       P52597; Q13351: KLF1; NbExp=3; IntAct=EBI-352986, EBI-8284732;
CC       P52597; Q9UIH9: KLF15; NbExp=3; IntAct=EBI-352986, EBI-2796400;
CC       P52597; Q5T749: KPRP; NbExp=3; IntAct=EBI-352986, EBI-10981970;
CC       P52597; O95678: KRT75; NbExp=3; IntAct=EBI-352986, EBI-2949715;
CC       P52597; Q8IUC3: KRTAP7-1; NbExp=3; IntAct=EBI-352986, EBI-18394498;
CC       P52597; Q14847-2: LASP1; NbExp=3; IntAct=EBI-352986, EBI-9088686;
CC       P52597; Q8TAP4-4: LMO3; NbExp=3; IntAct=EBI-352986, EBI-11742507;
CC       P52597; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-352986, EBI-739832;
CC       P52597; Q9NRX2: MRPL17; NbExp=3; IntAct=EBI-352986, EBI-7825154;
CC       P52597; O43347: MSI1; NbExp=3; IntAct=EBI-352986, EBI-726515;
CC       P52597; Q8NI38: NFKBID; NbExp=3; IntAct=EBI-352986, EBI-10271199;
CC       P52597; Q9BRJ7: NUDT16L1; NbExp=3; IntAct=EBI-352986, EBI-2949792;
CC       P52597; Q9HBE1-4: PATZ1; NbExp=3; IntAct=EBI-352986, EBI-11022007;
CC       P52597; Q9NR12: PDLIM7; NbExp=5; IntAct=EBI-352986, EBI-350517;
CC       P52597; P62937-2: PPIA; NbExp=3; IntAct=EBI-352986, EBI-25884072;
CC       P52597; P17252: PRKCA; NbExp=3; IntAct=EBI-352986, EBI-1383528;
CC       P52597; O75360: PROP1; NbExp=3; IntAct=EBI-352986, EBI-9027467;
CC       P52597; B1ATL7: PRR32; NbExp=3; IntAct=EBI-352986, EBI-18587059;
CC       P52597; Q9NV39: PRR34; NbExp=3; IntAct=EBI-352986, EBI-11959565;
CC       P52597; O43251: RBFOX2; NbExp=4; IntAct=EBI-352986, EBI-746056;
CC       P52597; O43251-10: RBFOX2; NbExp=3; IntAct=EBI-352986, EBI-11963050;
CC       P52597; Q04864-2: REL; NbExp=3; IntAct=EBI-352986, EBI-10829018;
CC       P52597; Q9BVN2: RUSC1; NbExp=3; IntAct=EBI-352986, EBI-6257312;
CC       P52597; Q15047-2: SETDB1; NbExp=3; IntAct=EBI-352986, EBI-9090795;
CC       P52597; Q8ND83: SLAIN1; NbExp=3; IntAct=EBI-352986, EBI-10269374;
CC       P52597; Q53HV7-2: SMUG1; NbExp=3; IntAct=EBI-352986, EBI-12275818;
CC       P52597; O60504: SORBS3; NbExp=3; IntAct=EBI-352986, EBI-741237;
CC       P52597; Q6RVD6: SPATA8; NbExp=3; IntAct=EBI-352986, EBI-8635958;
CC       P52597; Q96A09: TENT5B; NbExp=3; IntAct=EBI-352986, EBI-752030;
CC       P52597; Q92734: TFG; NbExp=3; IntAct=EBI-352986, EBI-357061;
CC       P52597; Q96PF1: TGM7; NbExp=3; IntAct=EBI-352986, EBI-12029034;
CC       P52597; Q08117: TLE5; NbExp=3; IntAct=EBI-352986, EBI-717810;
CC       P52597; Q08117-2: TLE5; NbExp=3; IntAct=EBI-352986, EBI-11741437;
CC       P52597; Q96RU7: TRIB3; NbExp=3; IntAct=EBI-352986, EBI-492476;
CC       P52597; Q14142: TRIM14; NbExp=3; IntAct=EBI-352986, EBI-2820256;
CC       P52597; Q9H9P5-5: UNKL; NbExp=3; IntAct=EBI-352986, EBI-12817837;
CC       P52597; Q70EL1-9: USP54; NbExp=3; IntAct=EBI-352986, EBI-11975223;
CC       P52597; Q99990: VGLL1; NbExp=3; IntAct=EBI-352986, EBI-11983165;
CC       P52597; A5D8V6: VPS37C; NbExp=3; IntAct=EBI-352986, EBI-2559305;
CC       P52597; P61981: YWHAG; NbExp=3; IntAct=EBI-352986, EBI-359832;
CC       P52597; A0A0C4DGF1: ZBTB32; NbExp=3; IntAct=EBI-352986, EBI-10188476;
CC       P52597; Q9P0T4: ZNF581; NbExp=3; IntAct=EBI-352986, EBI-745520;
CC       P52597; Q96H86: ZNF764; NbExp=3; IntAct=EBI-352986, EBI-745775;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm.
CC   -!- TISSUE SPECIFICITY: Expressed ubiquitously.
CC   -!- DOMAIN: The N-terminal RRM domains are responsible for recognizing the
CC       G-tract of BCL-X RNA.
CC   -!- PTM: Sumoylated. {ECO:0000269|PubMed:15161980}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L28010; AAC37584.1; -; mRNA.
DR   EMBL; AL512654; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK001364; BAG50896.1; -; mRNA.
DR   EMBL; CH471160; EAW86595.1; -; Genomic_DNA.
DR   EMBL; BC001432; AAH01432.1; -; mRNA.
DR   EMBL; BC004254; AAH04254.1; -; mRNA.
DR   EMBL; BC015580; AAH15580.1; -; mRNA.
DR   EMBL; BC016736; AAH16736.1; -; mRNA.
DR   EMBL; BC106008; AAI06009.1; -; mRNA.
DR   CCDS; CCDS7204.1; -.
DR   PIR; S43484; S43484.
DR   RefSeq; NP_001091674.1; NM_001098204.1.
DR   RefSeq; NP_001091675.1; NM_001098205.1.
DR   RefSeq; NP_001091676.1; NM_001098206.1.
DR   RefSeq; NP_001091677.1; NM_001098207.1.
DR   RefSeq; NP_001091678.1; NM_001098208.1.
DR   RefSeq; NP_004957.1; NM_004966.3.
DR   PDB; 2HGL; NMR; -; A=1-102.
DR   PDB; 2HGM; NMR; -; A=103-194.
DR   PDB; 2HGN; NMR; -; A=277-381.
DR   PDB; 2KFY; NMR; -; A=1-102.
DR   PDB; 2KG0; NMR; -; A=103-194.
DR   PDB; 2KG1; NMR; -; A=277-381.
DR   PDB; 3TFY; X-ray; 2.75 A; D/E/F=2-10.
DR   PDBsum; 2HGL; -.
DR   PDBsum; 2HGM; -.
DR   PDBsum; 2HGN; -.
DR   PDBsum; 2KFY; -.
DR   PDBsum; 2KG0; -.
DR   PDBsum; 2KG1; -.
DR   PDBsum; 3TFY; -.
DR   AlphaFoldDB; P52597; -.
DR   SMR; P52597; -.
DR   BioGRID; 109426; 553.
DR   CORUM; P52597; -.
DR   DIP; DIP-33145N; -.
DR   IntAct; P52597; 183.
DR   MINT; P52597; -.
DR   STRING; 9606.ENSP00000400433; -.
DR   ChEMBL; CHEMBL4523238; -.
DR   DrugBank; DB12695; Phenethyl Isothiocyanate.
DR   GlyCosmos; P52597; 1 site, 1 glycan.
DR   GlyGen; P52597; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P52597; -.
DR   MetOSite; P52597; -.
DR   PhosphoSitePlus; P52597; -.
DR   SwissPalm; P52597; -.
DR   BioMuta; HNRNPF; -.
DR   DMDM; 1710628; -.
DR   OGP; P52597; -.
DR   EPD; P52597; -.
DR   jPOST; P52597; -.
DR   MassIVE; P52597; -.
DR   MaxQB; P52597; -.
DR   PaxDb; P52597; -.
DR   PeptideAtlas; P52597; -.
DR   PRIDE; P52597; -.
DR   ProteomicsDB; 56497; -.
DR   Antibodypedia; 13432; 390 antibodies from 33 providers.
DR   DNASU; 3185; -.
DR   Ensembl; ENST00000337970.7; ENSP00000338477.3; ENSG00000169813.17.
DR   Ensembl; ENST00000356053.7; ENSP00000348345.3; ENSG00000169813.17.
DR   Ensembl; ENST00000357065.8; ENSP00000349573.4; ENSG00000169813.17.
DR   Ensembl; ENST00000443950.6; ENSP00000400433.2; ENSG00000169813.17.
DR   Ensembl; ENST00000544000.5; ENSP00000438061.1; ENSG00000169813.17.
DR   Ensembl; ENST00000682386.1; ENSP00000507787.1; ENSG00000169813.17.
DR   GeneID; 3185; -.
DR   KEGG; hsa:3185; -.
DR   MANE-Select; ENST00000682386.1; ENSP00000507787.1; NM_001098204.2; NP_001091674.1.
DR   UCSC; uc001jar.2; human.
DR   AGR; HGNC:5039; -.
DR   CTD; 3185; -.
DR   DisGeNET; 3185; -.
DR   GeneCards; HNRNPF; -.
DR   HGNC; HGNC:5039; HNRNPF.
DR   HPA; ENSG00000169813; Low tissue specificity.
DR   MIM; 601037; gene.
DR   neXtProt; NX_P52597; -.
DR   OpenTargets; ENSG00000169813; -.
DR   PharmGKB; PA162391271; -.
DR   VEuPathDB; HostDB:ENSG00000169813; -.
DR   eggNOG; KOG4211; Eukaryota.
DR   GeneTree; ENSGT00940000157838; -.
DR   HOGENOM; CLU_032003_1_0_1; -.
DR   InParanoid; P52597; -.
DR   OMA; ATEMDWA; -.
DR   OrthoDB; 314723at2759; -.
DR   PhylomeDB; P52597; -.
DR   TreeFam; TF316157; -.
DR   PathwayCommons; P52597; -.
DR   Reactome; R-HSA-6803529; FGFR2 alternative splicing.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   Reactome; R-HSA-8950505; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation.
DR   SignaLink; P52597; -.
DR   BioGRID-ORCS; 3185; 137 hits in 1170 CRISPR screens.
DR   ChiTaRS; HNRNPF; human.
DR   EvolutionaryTrace; P52597; -.
DR   GeneWiki; HNRPF; -.
DR   GenomeRNAi; 3185; -.
DR   Pharos; P52597; Tbio.
DR   PRO; PR:P52597; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; P52597; protein.
DR   Bgee; ENSG00000169813; Expressed in ventricular zone and 196 other tissues.
DR   ExpressionAtlas; P52597; baseline and differential.
DR   Genevisible; P52597; HS.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IBA:GO_Central.
DR   GO; GO:0045202; C:synapse; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB.
DR   GO; GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB.
DR   GO; GO:0006396; P:RNA processing; TAS:ProtInc.
DR   CDD; cd12729; RRM1_hnRNPH_hnRNPH2_hnRNPF; 1.
DR   CDD; cd12731; RRM2_hnRNPH_hnRNPH2_hnRNPF; 1.
DR   CDD; cd12506; RRM3_hnRNPH_CRSF1_like; 1.
DR   DisProt; DP01736; -.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR012996; Znf_CHHC.
DR   PANTHER; PTHR13976:SF32; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F; 1.
DR   PANTHER; PTHR13976; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN-RELATED; 1.
DR   Pfam; PF00076; RRM_1; 2.
DR   Pfam; PF08080; zf-RNPHF; 1.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 3.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Direct protein sequencing; Isopeptide bond;
KW   mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Ribonucleoprotein; RNA-binding; Spliceosome;
KW   Ubl conjugation.
FT   CHAIN           1..415
FT                   /note="Heterogeneous nuclear ribonucleoprotein F"
FT                   /id="PRO_0000367114"
FT   INIT_MET        1
FT                   /note="Removed; alternate"
FT                   /evidence="ECO:0000269|Ref.8, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895, ECO:0007744|PubMed:22814378"
FT   CHAIN           2..415
FT                   /note="Heterogeneous nuclear ribonucleoprotein F, N-
FT                   terminally processed"
FT                   /id="PRO_0000081852"
FT   DOMAIN          13..85
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          111..188
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          289..366
FT                   /note="RRM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          81..86
FT                   /note="Interaction with RNA"
FT   REGION          179..184
FT                   /note="Interaction with RNA"
FT   REGION          355..360
FT                   /note="Interaction with RNA"
FT   SITE            16
FT                   /note="Interaction with RNA"
FT   SITE            20
FT                   /note="Interaction with RNA"
FT   SITE            52
FT                   /note="Interaction with RNA"
FT   SITE            75
FT                   /note="Interaction with RNA"
FT   SITE            116
FT                   /note="Interaction with RNA"
FT   SITE            120
FT                   /note="Interaction with RNA"
FT   SITE            150
FT                   /note="Interaction with RNA"
FT   SITE            173
FT                   /note="Interaction with RNA"
FT   SITE            294
FT                   /note="Interaction with RNA"
FT   SITE            298
FT                   /note="Interaction with RNA"
FT   SITE            326
FT                   /note="Interaction with RNA"
FT   SITE            349
FT                   /note="Interaction with RNA"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine; in Heterogeneous nuclear
FT                   ribonucleoprotein F; alternate"
FT                   /evidence="ECO:0000269|Ref.8, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22814378"
FT   MOD_RES         2
FT                   /note="N-acetylmethionine; in Heterogeneous nuclear
FT                   ribonucleoprotein F, N-terminally processed"
FT                   /evidence="ECO:0000269|Ref.8, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895, ECO:0007744|PubMed:22814378"
FT   MOD_RES         104
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         161
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17525332"
FT   MOD_RES         187
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         193
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         195
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q794E4"
FT   MOD_RES         200
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2X1"
FT   MOD_RES         215
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         224
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         265
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   CROSSLNK        72
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000269|PubMed:15161980"
FT   CROSSLNK        87
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        167
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        185
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        200
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:25772364,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        224
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VARIANT         87
FT                   /note="K -> R (in dbSNP:rs17851426)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_027999"
FT   MUTAGEN         20
FT                   /note="W->A: Loss of RNA-binding."
FT                   /evidence="ECO:0000269|PubMed:20526337"
FT   MUTAGEN         84
FT                   /note="E->A: Loss of RNA-binding."
FT                   /evidence="ECO:0000269|PubMed:20526337"
FT   MUTAGEN         116
FT                   /note="R->A: Decreases affinity for RNA oligonucleotide
FT                   100-fold."
FT                   /evidence="ECO:0000269|PubMed:20526337"
FT   MUTAGEN         120
FT                   /note="F->A: Little disruption of binding RNA. Decreases
FT                   affinity for RNA oligonucleotide 100-fold. Abrogates
FT                   RNA-binding; when associated with A-180."
FT                   /evidence="ECO:0000269|PubMed:16885237,
FT                   ECO:0000269|PubMed:20526337"
FT   MUTAGEN         150
FT                   /note="K->A: No effect on affinity for RNA
FT                   oligonucleotide."
FT                   /evidence="ECO:0000269|PubMed:20526337"
FT   MUTAGEN         156
FT                   /note="F->A: Drastically effects folding of RRM2."
FT                   /evidence="ECO:0000269|PubMed:16885237"
FT   MUTAGEN         173
FT                   /note="K->A: Minimal effect on affinity for RNA
FT                   oligonucleotide."
FT                   /evidence="ECO:0000269|PubMed:20526337"
FT   MUTAGEN         178
FT                   /note="H->A: Little disruption of binding RNA."
FT                   /evidence="ECO:0000269|PubMed:16885237"
FT   MUTAGEN         179
FT                   /note="R->A: Decreases affinity for RNA oligonucleotide
FT                   100-fold."
FT                   /evidence="ECO:0000269|PubMed:20526337"
FT   MUTAGEN         180
FT                   /note="Y->A: Decreases affinity for RNA oligonucleotide
FT                   10-fold. Abrogates RNA-binding; when associated with
FT                   A-120."
FT                   /evidence="ECO:0000269|PubMed:16885237,
FT                   ECO:0000269|PubMed:20526337"
FT   MUTAGEN         182
FT                   /note="E->A: Decreases affinity for RNA oligonucleotide
FT                   100-fold."
FT                   /evidence="ECO:0000269|PubMed:20526337"
FT   MUTAGEN         184
FT                   /note="F->A: Minimal effect on affinity for RNA
FT                   oligonucleotide."
FT                   /evidence="ECO:0000269|PubMed:20526337"
FT   STRAND          12..17
FT                   /evidence="ECO:0007829|PDB:2HGL"
FT   HELIX           24..30
FT                   /evidence="ECO:0007829|PDB:2HGL"
FT   TURN            31..33
FT                   /evidence="ECO:0007829|PDB:2HGL"
FT   STRAND          37..40
FT                   /evidence="ECO:0007829|PDB:2HGL"
FT   STRAND          43..47
FT                   /evidence="ECO:0007829|PDB:2HGL"
FT   STRAND          49..51
FT                   /evidence="ECO:0007829|PDB:2HGL"
FT   STRAND          53..60
FT                   /evidence="ECO:0007829|PDB:2HGL"
FT   HELIX           64..71
FT                   /evidence="ECO:0007829|PDB:2HGL"
FT   TURN            72..74
FT                   /evidence="ECO:0007829|PDB:2HGL"
FT   STRAND          75..87
FT                   /evidence="ECO:0007829|PDB:2HGL"
FT   HELIX           90..97
FT                   /evidence="ECO:0007829|PDB:2HGL"
FT   STRAND          107..109
FT                   /evidence="ECO:0007829|PDB:2HGM"
FT   STRAND          112..116
FT                   /evidence="ECO:0007829|PDB:2HGM"
FT   HELIX           124..130
FT                   /evidence="ECO:0007829|PDB:2HGM"
FT   TURN            131..133
FT                   /evidence="ECO:0007829|PDB:2HGM"
FT   STRAND          136..142
FT                   /evidence="ECO:0007829|PDB:2HGM"
FT   STRAND          147..151
FT                   /evidence="ECO:0007829|PDB:2HGM"
FT   STRAND          153..161
FT                   /evidence="ECO:0007829|PDB:2HGM"
FT   HELIX           164..169
FT                   /evidence="ECO:0007829|PDB:2HGM"
FT   TURN            170..173
FT                   /evidence="ECO:0007829|PDB:2HGM"
FT   STRAND          175..180
FT                   /evidence="ECO:0007829|PDB:2KG0"
FT   STRAND          184..186
FT                   /evidence="ECO:0007829|PDB:2HGM"
FT   HELIX           188..191
FT                   /evidence="ECO:0007829|PDB:2HGM"
FT   STRAND          284..294
FT                   /evidence="ECO:0007829|PDB:2KG1"
FT   HELIX           302..309
FT                   /evidence="ECO:0007829|PDB:2HGN"
FT   STRAND          315..318
FT                   /evidence="ECO:0007829|PDB:2HGN"
FT   STRAND          322..325
FT                   /evidence="ECO:0007829|PDB:2HGN"
FT   STRAND          332..334
FT                   /evidence="ECO:0007829|PDB:2HGN"
FT   HELIX           337..344
FT                   /evidence="ECO:0007829|PDB:2HGN"
FT   STRAND          351..354
FT                   /evidence="ECO:0007829|PDB:2HGN"
FT   STRAND          358..362
FT                   /evidence="ECO:0007829|PDB:2KG1"
FT   STRAND          368..371
FT                   /evidence="ECO:0007829|PDB:2KG1"
FT   STRAND          377..379
FT                   /evidence="ECO:0007829|PDB:2KG1"
SQ   SEQUENCE   415 AA;  45672 MW;  D14E170631FB1F31 CRC64;
     MMLGPEGGEG FVVKLRGLPW SCSVEDVQNF LSDCTIHDGA AGVHFIYTRE GRQSGEAFVE
     LGSEDDVKMA LKKDRESMGH RYIEVFKSHR TEMDWVLKHS GPNSADSAND GFVRLRGLPF
     GCTKEEIVQF FSGLEIVPNG ITLPVDPEGK ITGEAFVQFA SQELAEKALG KHKERIGHRY
     IEVFKSSQEE VRSYSDPPLK FMSVQRPGPY DRPGTARRYI GIVKQAGLER MRPGAYSTGY
     GGYEEYSGLS DGYGFTTDLF GRDLSYCLSG MYDHRYGDSE FTVQSTTGHC VHMRGLPYKA
     TENDIYNFFS PLNPVRVHIE IGPDGRVTGE ADVEFATHEE AVAAMSKDRA NMQHRYIELF
     LNSTTGASNG AYSSQVMQGM GVSAAQATYS GLESQSVSGC YGAGYSGQNS MGGYD
//
